Severe Type of Erythema Multiforme (EM major) due to Administration of Anti-PD-1 Antibody Drug
Author(s) -
Shoya Yano,
Aika Okuno,
Fukumi Furukawa
Publication year - 2021
Publication title -
trends in immunotherapy
Language(s) - English
Resource type - Journals
ISSN - 2573-5985
DOI - 10.24294/ti.v5.i1.1247
Subject(s) - toxic epidermal necrolysis , erythema multiforme , discontinuation , medicine , dermatology , drug , erythema , pharmacology
Immune checkpoint inhibitors can sometimes cause unexpected skin side effects. Special attention should be paid to a severe form of erythema multiforme (EM), toxic epidermal necrolysis and Stevens-Johnson syndrome. We experienced a patient who took 10 weeks from drug discontinuation to the onset of EM major.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom